Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
11/2001
11/21/2001CN1323396A Endogenous constitutively activated G protein-coupled orphan receptors
11/21/2001CN1322526A Compound for treating female sexual dysfunction
11/15/2001WO2001085722A1 Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors
11/15/2001WO2001040185B1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
11/15/2001US20010041703 Which are growth hormone secretogogues and increase the level of endogenous growth hormone; treating osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair
11/15/2001CA2408156A1 Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors
11/14/2001EP1123937A9 Substance gm-95, process for producing the same and utilization thereof
11/14/2001EP0763037B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF
11/14/2001EP0686613B1 Ozonide reducing agent
11/13/2001US6316503 For therapy of disease states associated with cholesterol metabolism such as atherosclerosis and hypercholesterolemia
11/13/2001US6316442 Treatment of heart disease and cerebrovascular disturbances
11/08/2001WO2001083484A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
11/08/2001WO2001083460A1 Cyclic compounds
11/08/2001CA2407231A1 Cyclic compounds
11/07/2001EP0802917B1 Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
11/07/2001CN1321153A Telomerase inhibitors and method of their use
11/07/2001CN1320597A Antifungal and its preparation method and intermediate
11/07/2001CN1320426A Compound for treatment of female sexual dysfuction
11/06/2001US6313127 For therapy of hypercholesterolemia or atherosclerosis
11/06/2001US6313109 Prenyl transferase inhibitors
11/01/2001WO2001081344A1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines
11/01/2001US20010037030 Tricyclic amine derivatives
11/01/2001CA2402808A1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines
10/2001
10/31/2001EP1149106A2 4,5-azolo-oxindoles
10/31/2001EP0624160B1 2-isocephem and oxacephem derivatives, processes for their preparation, intermediates thereof and use as antibacterial agents
10/31/2001CN1320126A Oxazolo, thiazolo and selenazolo [4,5-C]-quinolin-4-amines and analoges thereof
10/30/2001US6310075 Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
10/30/2001CA2113189C Diaminic compounds, preparation, use and intermediates
10/30/2001CA2084669C [3h,7h]thiazolo[3,4-a]pyridines with antiasthmatic and a antiinflammatory actions on the respiratory tract
10/25/2001WO2001079209A2 Diazafluorenone il-8 antagonists
10/25/2001WO2001079187A2 Substituted 1,4-thiazepine and analogs and their use as activators of caspases
10/25/2001WO2001025238A3 Heterocyclic compounds useful as inhibitors of tyrosine kinases
10/25/2001US20010034350 Indolo[2,1-b] quinazole-6,12-dione antimalarial compounds and methods of treating malaria therewith
10/25/2001US20010033944 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied
10/25/2001CA2406271A1 Substituted 1,4-thiazepine and analogs and their use as activators of caspases
10/24/2001EP1148059A1 Thiazolopyrimidine compounds, process for the preparation of the same and uses thereof
10/24/2001EP1147115A2 Tricyclic benzodiazepines as vasopressin receptor antagonists
10/23/2001US6306851 Cyclocarbamate and cyclic amide derivatives
10/18/2001WO2001077116A1 Inhibitors of prenyl-protein transferase
10/18/2001WO2001077114A1 Inhibitors of prenyl-protein transferase
10/18/2001WO2001077101A1 Chemical compounds
10/18/2001WO2001076694A1 Inhibitors of prenyl-protein transferase
10/18/2001WO2001076693A1 Inhibitors of prenyl-protein transferase
10/18/2001WO2001027087A3 Process for making boc-protected 3-aminohydantoins/thiohydantoins and 3-aminodihydrouracils/dihydrothiouracils
10/18/2001US20010031765 Antiviral compounds
10/18/2001CA2403012A1 Chemical compounds
10/17/2001EP1144396A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
10/17/2001EP1144387A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
10/17/2001EP1144368A2 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
10/17/2001EP1143951A2 Antimalarial agents
10/17/2001EP1143943A2 P53 inhibitors and their use for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant
10/16/2001US6303720 Olefin polymerization catalysts containing group 8-10 transition metals, processes employing such catalysts and polymers obtained therefrom
10/16/2001US6303614 Tetrahydro gamma-carbolines
10/16/2001US6303342 Recombinant methods and materials for producing epothilones C and D
10/11/2001WO2001074774A1 Ethylenediamine derivatives
10/11/2001WO2001074348A2 Vasopeptidase inhibitors to treat isolated systolic hypertension
10/11/2001WO2001027119A3 Substance library containing bicyclic imidazo-5-yl-amines and/or bicyclic imidazo-3-yl-amines
10/11/2001WO2001002377A9 Telomerase inhibitors and methods of their use
10/11/2001WO2000016763A3 Antimalarial agents
10/11/2001CA2405496A1 Vasopeptidase inhibitors to treat isolated systolic hypertension
10/11/2001CA2405144A1 Ethylenediamine derivatives
10/10/2001EP1140945A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use
10/10/2001EP1140915A1 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
10/10/2001EP1140871A1 Thrombin or factor xa inhibitors
10/10/2001EP1140862A1 THROMBIN OR FACTOR Xa INHIBITORS
10/10/2001EP1140097A2 Products comprising trihydroxystilbenes and derivatives thereof and methods for their manufacture and use
10/10/2001EP1140091A2 Formulations comprising imiquimod or other immune response modifiers for treating mucosal consitions
10/10/2001EP1140085A1 Azabicycloalkanes as ccr5 modulators
10/04/2001WO2001073438A1 Ricin inhibitors and methods for use thereof
10/04/2001WO2001072758A1 Tricyclic protein kinase inhibitors
10/04/2001US20010027197 Antiproliverative, -carcinogenic and -tumor agents; mitogenesis-activated protein kinase inhibitors; noncytotoxic; binding with high affinity at the adenosine triphosphate binding site of the kinases
10/04/2001EP0973395A4 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
10/04/2001CA2404445A1 Tricyclic protein kinase inhibitors
10/03/2001CN1072224C Condensed 'beta'-carbolines
09/2001
09/27/2001WO2001070749A1 A process for preparing cephalosporin derivatives using new thiazole compound
09/27/2001WO2001070677A1 Sulphonamido-substituted bridged bicycloalkyl derivatives
09/27/2001US20010025047 Nitrogen containing bicyclic heteroaromatic compound containing sulfonamide and hydroxyamide groups, useful in treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, bone disease and HIV infections
09/27/2001US20010025007 Contacting one or more olefin monomers with a Group 8-10 transition metal complex catalyst and optionally a Bronsted or Lewis acid
09/27/2001DE19960898A1 Preparation of a wide range of annelated pyrroles useful as photographic cyan dye couplers by reaction of heterocyclic carbonyl compounds with substituted phosphoric oxides or phosphonium salts in presence of a strong base
09/27/2001DE10046728C1 New mercaptomethyl-substituted tricyclic quinazolinone derivatives, are matrix metalloprotease inhibitors useful for treating cancer, rheumatism, inflammatory reactions or allergies
09/26/2001EP1135470A2 Recombinant methods and materials for producing epothilone and epothilone derivatives
09/26/2001EP0773943B1 Compounds useful as antiproliferative agents and garft inhibitors
09/26/2001CN1314891A Synthesis of benzo (F) quinolinones
09/25/2001CA2059999C Process for preparing 2'-(diethylamino)rifamycin p (p/dea)
09/20/2001WO2001068653A1 Dihydroimidazo[2,1-b]thiazole and dihydro-5h-thiazolo[3,2-a]pyrimidines as antidepressant agents
09/20/2001WO2001027118A3 Bicyclic imidazo-5-yl-amine derivatives
09/20/2001WO2001027110A3 Bicyclic imidazo-3-yl-amine derivatives which are substituted on the sixth ring
09/20/2001WO2001027109A3 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives
09/20/2001CA2402427A1 Dihydroimidazo[2,1-b]thiazole and dihydro-5h-thiazolo[3,2-a]pyrimidines as antidepressant agents
09/19/2001EP1133293A1 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
09/19/2001CN1313855A Inhibitors of alpha4Betal mediated cell adhesion alpha Beta
09/18/2001US6291474 Bicyclic amine derivatives
09/18/2001CA2236814C Quinoline and quinazoline compounds useful in therapy
09/13/2001WO2001066546A1 Spiro compounds, process for preparing the same and use thereof as drugs
09/13/2001WO2001066112A1 Urease inhibitors
09/13/2001WO2001028992A3 New oxabispidine compounds useful in the treatment of cardiac arrhythmias
09/13/2001CA2400527A1 Urease inhibitors
09/12/2001EP0793665B1 Heterocyclic compounds and their preparation and use
09/12/2001CN1070855C 4-thiocarbamoyl-1-(3-pyrazoly)-pyrazoles and their use as herbicides
09/11/2001US6288094 Polycyclic thiazol-2-ylidene amines, processes for their preparation and their use as medicaments
1 ... 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 ... 152